Free Trial

Arteris, Inc. (NASDAQ:AIP) COO Laurent R. Moll Sells 34,400 Shares

Arteris logo with Computer and Technology background

Key Points

  • The COO of Arteris, Inc., Laurent R. Moll, sold 34,400 shares at an average price of $13.57, totaling approximately $466,808, resulting in a 7.22% decrease in his ownership stake.
  • Following his sale, Moll retains 442,071 shares in the company, valued at nearly $6 million, while Arteris' stock has a current trading price of $9.31.
  • Several analyst reports have rated Arteris with a "buy" recommendation, with price targets ranging from $14.00 to $15.00, highlighting positive sentiment on the stock despite recent declines.
  • Want stock alerts on Arteris? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent R. Moll sold 34,400 shares of the firm's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.57, for a total value of $466,808.00. Following the completion of the sale, the chief operating officer directly owned 442,071 shares in the company, valued at approximately $5,998,903.47. The trade was a 7.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Arteris Trading Down 5.9%

AIP stock traded down $0.58 during midday trading on Thursday, hitting $9.31. The company had a trading volume of 2,288,956 shares, compared to its average volume of 535,557. The stock has a market cap of $390.83 million, a price-to-earnings ratio of -11.35 and a beta of 1.45. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $14.29. The stock's 50 day moving average price is $9.09 and its 200 day moving average price is $8.40.

Analyst Ratings Changes

AIP has been the topic of a number of recent analyst reports. Rosenblatt Securities reaffirmed a "buy" rating and issued a $14.00 target price on shares of Arteris in a research note on Wednesday, May 21st. TD Cowen lifted their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday.

Read Our Latest Research Report on Arteris

Institutional Investors Weigh In On Arteris

A number of large investors have recently modified their holdings of AIP. G2 Investment Partners Management LLC bought a new position in shares of Arteris in the 4th quarter worth approximately $2,799,000. Acadian Asset Management LLC lifted its position in Arteris by 40.6% during the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after acquiring an additional 260,277 shares during the period. AQR Capital Management LLC bought a new stake in Arteris during the first quarter worth about $1,621,000. Federated Hermes Inc. grew its holdings in Arteris by 97.2% in the first quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock worth $2,260,000 after purchasing an additional 161,241 shares during the period. Finally, Next Century Growth Investors LLC increased its stake in shares of Arteris by 46.4% during the first quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock valued at $2,817,000 after purchasing an additional 129,143 shares in the last quarter. Institutional investors own 64.36% of the company's stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines